Capital Market Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,372
| Closed | -$214K | – | 157 |
|
|
2024
Q3 | $214K | Sell |
8,372
-629
| -7% | -$16.1K | 0.13% | 137 |
|
|
2024
Q2 | $211K | Sell |
9,001
-243
| -3% | -$5.71K | 0.13% | 139 |
|
|
2024
Q1 | $266K | Sell |
9,244
-405
| -4% | -$11.6K | 0.2% | 113 |
|
|
2023
Q4 | $317K | Sell |
9,649
-135
| -1% | -$4.43K | 0.28% | 93 |
|
|
2023
Q3 | $259K | Sell |
9,784
-510
| -5% | -$13.5K | 0.26% | 103 |
|
|
2023
Q2 | $351K | Sell |
10,294
-515
| -5% | -$17.6K | 0.32% | 80 |
|
|
2023
Q1 | $325K | Buy |
10,809
+350
| +3% | +$10.5K | 0.58% | 33 |
|
|
2022
Q4 | $295K | Sell |
10,459
-441
| -4% | -$12.5K | 0.32% | 87 |
|
|
2022
Q3 | $358K | Sell |
10,900
-348
| -3% | -$11.4K | 0.4% | 68 |
|
|
2022
Q2 | $354K | Sell |
11,248
-396
| -3% | -$12.5K | 0.37% | 74 |
|
|
2022
Q1 | $535K | Buy |
11,644
+999
| +9% | +$45.9K | 0.46% | 54 |
|
|
2021
Q4 | $652K | Buy |
+10,645
| New | +$652K | 0.54% | 45 |
|